- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02483377
Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer
Breast Cancer Patient Navigation and Tailored Treatment Planning: A Process Evaluation Study for LAC+USC Patient Navigation, Treatment Planning, and Ongoing Support for Latina Women
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
PRIMARY OBJECTIVES:
I. Successful navigation of patients being screened or treated for breast cancer through the continuum of their care (from visit to visit; from surgical care to radiologic care to oncologic care; from oncologic care to supportive care; etc).
II. Supply individualized in-language treatment summaries and follow-up care plans to enrolled patients.
III. Supply tailored in-language survivorship plan summaries to enrolled patients.
OUTLINE:
Patients receive treatment summaries and plan report that captures patient data through the use of an "intake checklist" completed during the initial consultation with the breast oncology team and used to guide referrals to existing services and programmed with generic information related to disease and treatment management plan. Additional elements, such as psycho-social services, exercise, and/or nutrition, identified by the patient self-report, will be incorporated. Patients also complete 3 questionnaires at each clinic visit.
After completion of study, patients are followed up at 6 months or 12 months.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
California
-
Los Angeles, California, États-Unis, 90033
- USC / Norris Comprehensive Cancer Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Patients receiving ongoing care at LAC+USC
- Self-identified as Latina (or Hispanic)
- Known or suspected breast cancer
- Being seen in a breast cancer high risk, screening or prevention program or clinic or in one of the breast cancer clinics (surgical or medical oncology)
Exclusion Criteria:
- Inability to sign informed consent or complete questionnaires and forms
- Self-identified as non-Latina (or non-Hispanic)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Observational (treatment summaries and plan report)
Patients receive treatment summaries and plan report that captures patient data through the use of an "intake checklist" completed during the initial consultation with the breast oncology team and used to guide referrals to existing services and programmed with generic information related to disease and treatment management plan.
Additional elements, such as psycho-social services, exercise, and/or nutrition, identified by the patient self-report, will be incorporated.
Patients also complete 3 questionnaires at each clinic visit.
|
Etudes annexes
Autres noms:
Remplir des questionnaires
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Number of missed appointments from the time of initial diagnosis to the completion of primary treatment (chemotherapy, surgery and radiation as applicable) as measured by CCCQ
Délai: Up to 12 months
|
Questionnaire scores will be expressed as median values with 95% confidence intervals.
|
Up to 12 months
|
Number of patients enrolled on clinical trials (interventional and non-interventional)
Délai: Up to 12 months
|
Number of patients enrolled on clinical trials (interventional and non-interventional) will be quantified and compared to historical controls.
|
Up to 12 months
|
Number of special referrals made
Délai: Up to 12 months
|
Number of special referrals made (eg.
social worker, genetic counseling, fertility) through the navigation system will quantified and compared to historical controls.
|
Up to 12 months
|
Overall experience with breast cancer (broadly) and at LAC+USC as measured by experience-based questionnaire
Délai: Up to 12 months
|
Up to 12 months
|
|
Usefulness, accessibility, and quality of the patient navigation model as measured by Continuity/Coordination of Care Questionnaire (CCCQ)
Délai: Up to 12 months
|
Means and standard deviations will be summarized per outcome measures at 3, 6, and 12 months after baseline, and 95% confidence intervals for the difference in means will be calculated for each assessment time for total scores and subscale scores.
|
Up to 12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Heather Macdonald, University of Southern California
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1B-14-7 (Autre identifiant: USC / Norris Comprehensive Cancer Center)
- P30CA014089 (Subvention/contrat des NIH des États-Unis)
- NCI-2015-00351 (Identificateur de registre: CTRP (Clinical Trial Reporting Program))
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Carcinome du sein
-
AstraZenecaRecrutementAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerEspagne, États-Unis, Belgique, Royaume-Uni, France, Hongrie, Canada, Corée, République de, Australie
Essais cliniques sur Évaluation de la qualité de vie
-
Taipei City HospitalComplétéInfections à VIH | Qualité de vieTaïwan
-
Ankara Etlik City HospitalPas encore de recrutementÉchelle de fragilitéTurquie
-
Avicenna Military HospitalComplétéRécupération postopératoireMaroc
-
Memorial Sloan Kettering Cancer CenterRésiliéLes familles ou proches parents des patients traités au MSKCC pour des carcinomes épidermoïdes non cutanés du | Voies aérodigestives supérieuresÉtats-Unis
-
Assiut UniversityPas encore de recrutement
-
Alexandria UniversityComplétéDialyse; ComplicationsEgypte
-
Samuel Lunenfeld Research Institute, Mount Sinai...ComplétéQualité de récupérationCanada
-
Won Choi, PhD, MPHNational Cancer Institute (NCI)ComplétéSevrage tabagiqueÉtats-Unis